{"id":31759,"date":"2025-03-31T10:53:00","date_gmt":"2025-03-31T02:53:00","guid":{"rendered":"https:\/\/flcube.com\/?p=31759"},"modified":"2025-04-15T10:59:39","modified_gmt":"2025-04-15T02:59:39","slug":"bioray-biopharmaceutical-expands-to-turkey-with-three-key-drugs-marking-international-milestone","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31759","title":{"rendered":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone"},"content":{"rendered":"\n<p>Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.<\/p>\n\n\n\n<p><strong>Drug Profile and Applications<\/strong><br>Infliximab and trastuzumab have already received marketing approval in China. Infliximab is used to treat autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis, while trastuzumab is indicated for the treatment of tumors including breast and stomach cancers. Pertuzumab, when used in combination with trastuzumab, significantly enhances anti-tumor efficacy. Its marketing application was accepted by China\u2019s National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) in October 2024.<\/p>\n\n\n\n<p><strong>Global Expansion and Future Outlook<\/strong><br>Since initiating its international business in 2022, Bioray Biopharmaceutical has actively advanced its global\u5e03\u5c40, establishing collaborations in over 30 countries and regions. To date, the company\u2019s products have been approved for marketing in three overseas countries\/regions, and it has successfully completed six overseas GMP inspections, laying a solid foundation for international product launch. Looking ahead, Bioray Biopharmaceutical will continue to drive innovation and accelerate its internationalization process, aiming to provide more high-quality treatment options for patients worldwide.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration&#8230;<\/p>\n","protected":false},"author":1,"featured_media":31760,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,11],"tags":[2575],"class_list":["post-31759","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-drug","tag-bioray-pharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31759\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone\" \/>\n<meta property=\"og:description\" content=\"Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31759\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-31T02:53:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-15T02:59:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone\",\"datePublished\":\"2025-03-31T02:53:00+00:00\",\"dateModified\":\"2025-04-15T02:59:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759\"},\"wordCount\":221,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/3101-png.webp\",\"keywords\":[\"BioRay Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31759#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31759\",\"name\":\"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/3101-png.webp\",\"datePublished\":\"2025-03-31T02:53:00+00:00\",\"dateModified\":\"2025-04-15T02:59:39+00:00\",\"description\":\"Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31759\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/3101-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/3101-png.webp\",\"width\":1080,\"height\":608,\"caption\":\"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31759#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone - Insight, China&#039;s Pharmaceutical Industry","description":"Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31759","og_locale":"en_US","og_type":"article","og_title":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone","og_description":"Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.","og_url":"https:\/\/flcube.com\/?p=31759","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-31T02:53:00+00:00","article_modified_time":"2025-04-15T02:59:39+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31759#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31759"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone","datePublished":"2025-03-31T02:53:00+00:00","dateModified":"2025-04-15T02:59:39+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31759"},"wordCount":221,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31759#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp","keywords":["BioRay Pharmaceutical"],"articleSection":["Company","Deals","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31759#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31759","url":"https:\/\/flcube.com\/?p=31759","name":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31759#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31759#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp","datePublished":"2025-03-31T02:53:00+00:00","dateModified":"2025-04-15T02:59:39+00:00","description":"Zhejiang Bioray Biopharmaceutical Co., Ltd. announced on March 31 that it has reached a collaboration with a partner to launch three independently developed drugs\u2014infliximab, trastuzumab, and pertuzumab\u2014in the Turkish market. This strategic move marks a significant milestone in the company\u2019s internationalization efforts, further expanding its global footprint.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31759#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31759"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31759#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp","width":1080,"height":608,"caption":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31759#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/3101-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31759"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31759\/revisions"}],"predecessor-version":[{"id":31761,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31759\/revisions\/31761"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31760"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}